Phreesia, Inc.
PHRAbout the company
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Investment snapshot
Positive
0
BUY / PASS
Neutral / negative
3 / 13
NEUTRAL / FAIL
Median fair value
$6.75
-46.8% vs price
Models with upside
2 / 17
Positive margin of safety
Strongest signal
9 of 12 pass — Buffett, Marks and Asness object
Key risk
Split decision: 13 FAIL · 3 NEUTRAL
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #1664 (Top 53.7%) | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||
| Margin of Safety | -466.5% | -187.8% | N/A | N/A | N/A | N/A | +52.3% | -88.0% | N/A | N/A | +68.2% | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Annual history · FY 2025 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-07-31 · TTM ended 2026-07-31 vs 2025-07-31 · TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-31 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Market data at 2026-11-01 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-31 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-07-31 · Qualitative assessment Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Market data at 2026-11-01 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-31 Score computed: 2026-11-14 | TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14 | TTM ended 2026-07-31 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-09-03 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage75% pass✓ 12✗ 3▾
9 of 12 pass — Buffett, Marks and Asness object
LT Debt vs Net Current AssetsLT Debt $1.1M vs NCA $109.7M✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.18, IC: 1.2x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.18✓Lynch< 0.33Cash - Long-term Debt$73.5M✓LynchPositive preferredLT Debt / Total Assets Change0.50% -> 0.40%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.76✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.18✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.18✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=1.2x, D/EBITDA=1.3x✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.18✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.1787; #1606/4210 (top 38.1%)✗AsnessTop 30% of eligible cross-section
Where It Falls Short
- Verdicts0% pass✗ 14▾
Split decision: 13 FAIL · 3 NEUTRAL
Overall verdict✗GrahamFAIL (2/9)✗BuffettFAIL (1/9)✗LynchFAIL (4/7)✗GreenblattRank #1664•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (0/5)•AckmanNEUTRAL (6/9)✗TempletonFAIL (3/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #1481/2370 (Top 62.5%))✗NeffFAIL (2/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Profitability6% pass✓ 7✗ 28▾
15 of 16 flag PHR's profitability — Graham, Buffett, Lynch +12 more
Positive EPS (10 years)1/10 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)1/10 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-33.1%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-1.4% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$22.7M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 317.2x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE2.8%✗Lynch> 15%EBIT / Enterprise Value1.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=1.6%, ROC=10.6%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets0.35%✓PiotroskiROA > 0ROA Change YoY-15.07% -> 0.35% (delta: +15.42%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=11.87%, ROA=0.35%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY84.2% -> 85.2%✓PiotroskiImproved YoYPre-Tax Income / Revenue0.5%✗Dreman>= 8%Net Income / Shareholders' Equity2.8%✗Dreman> 12%Margin of SafetyP/E=317.2x, P/B=2.3x✗PabraiP/B < 1.5 or P/E < 15Return on Equity-25.3% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency1/9 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue2.5%✗Ackman>= 15%Net Income / Shareholders Equity2.8%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-38.3% (2023) -> -1.4% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 82.9% -> 85.2%, operating margin -38.3% -> -1.4%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+1.33%; #2902/6340 (top 45.8%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+61.65%; #444/3702 (top 12.0%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity+2.81%; #2692/5226 (top 51.5%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.1671; #4038/5884 (top 68.6%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years1/9 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation8% pass✓ 1✗ 27▾
12 of 13 flag PHR's valuation — Graham, Lynch, Greenblatt +9 more
Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio2.3x✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 317.2x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value1.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=1.6%, ROC=10.6%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS317.2x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)9.8x✗Dreman< 8xPrice / Book Value per Share2.3x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=317.2x, OE Yield=2.9%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=317.2x, FCF Yield=8.6%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=317.2x, P/B=2.3x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per Share11.4x✓Ackman<= 25Price vs. Trailing Low151% of trailing low ($8.38)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+1.33%; #2902/6340 (top 45.8%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.4721; #2990/6449 (top 46.4%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS317.2x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share8.82x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change-5.4%✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.6447; #2307/5247 (top 44.0%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+10.25%; #734/4519 (top 16.2%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+37.79%; #851/6202 (top 13.7%)✗OshaughnessyTop 10% of eligible cross-section - Growth13% pass✓ 4✗ 9▾
7 of 8 flag PHR's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 317.2x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency1/9 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth17.8%✓Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 82.9% -> 85.2%, operating margin -38.3% -> -1.4%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR26.4%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency13% pass✓ 1✗ 10▾
7 of 8 flag PHR's efficiency — Graham, Buffett, Greenblatt +4 more
Current Ratio1.76✗Graham>= 2.0ROIC (3-5 yr avg)-56.5%✗Buffett> 10%ROIC - WACC-66.5%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)10.6%✗Greenblatt> 25%Current Ratio Change YoY1.78 -> 1.53✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.08x -> 0.72x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.76✓Dreman> 1.5Return on Invested Capital2.3%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=-41.0%; FY2024: ROIC=-16.3%; FY2025: ROIC=-1.2%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC-1.2% (RR=100% x ROIC=-1.2%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/5 years above 12% (latest -1.2%)✗SleepROIC > 12% in a majority of years - Valuation models40% pass✓ 2✗ 3▾
Models split on PHR at $12.69 — fair values range $2.24–$39.95
Graham fair value$2.24✗Graham-466.5% margin vs $12.69Buffett fair value$4.41✗Buffett-187.8% margin vs $12.69Munger fair value$26.60✓Munger+52.3% margin vs $12.69Pabrai fair value$6.75✗Pabrai-88.0% margin vs $12.69Ackman fair value$39.95✓Ackman+68.2% margin vs $12.69 - Cash Flow50% pass✓ 7✗ 5▾
5 of 10 pass — Dreman, Pabrai, Marks +2 more object
Free Cash Flow Proxy$22.7M✓BuffettPositive and growingFCF Positive and Growing$80.7M✓LynchPositive and growingOperating Cash Flow$78.8M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=11.87%, ROA=0.35%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)9.8x✗Dreman< 8xP/E or FCF YieldP/E=317.2x, FCF Yield=8.6%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive2/9 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap10.5%✓Ackman>= 4%Price / FCF per Share11.4x✓Ackman<= 25Positive Operating Cash Flow frequency4/9 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$80.7M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+10.25%; #734/4519 (top 16.2%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 3.3% of shares last year, 7.7% issued over two.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-07-31 2025-08-01 – 2026-07-31 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex. | Q2 FY 2027 2026-05-01 – 2026-07-31 Sources | Q1 FY 2027 2026-02-01 – 2026-04-30 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|
| Market Cap | $787.7Mcurrent | -- | -- | $815.4Mest. | $1.7Best. | $1.4Best. | $2.0Best. | $1.6Best. |
| Revenue | $507.8M↑13% | $129.5M↑10% | $130.9M↑13% | $480.6M↑14% | $419.8M↑18% | $356.3M↑27% | $280.9M↑32% | $213.2M |
| Operating Income | $12.5M↑148% | $7.6M↑605% | $6.7M↑305% | -$6.6M↑89% | -$58.1M↑57% | -$136.5M↑23% | -$176.6M↓51% | -$116.8M |
| Net Income | $10.4M↑143% | $1.9M↑193% | $3.0M↑176% | $2.3M↑104% | -$58.5M↑57% | -$136.9M↑22% | -$176.1M↓49% | -$118.2M |
| EPS (Diluted) | -- | $0.03↑200% | $0.05↑171% | $0.04↑104% | $-1.02↑59% | $-2.51↑25% | $-3.36↓42% | $-2.37 |
| Gross Margin | — | — | — | 85.2%↑1% | 84.2%↑2% | 82.9%↑5% | 79.0%↓1% | 80.0% |
| Operating Margin | 2.5%↑142% | 5.9%↑557% | 5.2%↑282% | -1.4%↑90% | -13.8%↑64% | -38.3%↑39% | -62.9%↓15% | -54.8% |
| ROE | 2.8%↑135% | — | — | 0.7%↑103% | -22.1%↑59% | -54.4%↑11% | -61.2%↓116% | -28.3% |
| Total Debt | $66.4M↑469% | $66.4M↑469% | $90.6M↑524% | $100.1M↑518% | $16.2M↑41% | $11.5M↑45% | $7.9M↓40% | $13.2M |
| Shareholders' Equity | $371.9M↑25% | $371.9M↑25% | $359.1M↑27% | $337.2M↑27% | $264.8M↑5% | $251.4M↓13% | $287.8M↓31% | $417.3M |
| Current Ratio | 1.76↓17% | 1.76↓17% | 1.76↓10% | 1.53↓14% | 1.78 | 1.78↓46% | 3.32↓41% | 5.65 |
| Debt / Equity | 0.18↑356% | 0.18↑356% | 0.25↑391% | 0.30↑385% | 0.06↑34% | 0.05↑66% | 0.03↓14% | 0.03 |
| Operating Cash Flow | $91.4M↑77% | $18.3M↑24% | $23.9M↑61% | $78.8M↑143% | $32.4M↑200% | -$32.4M↑64% | -$90.1M↓21% | -$74.7M |
| Free Cash Flow | $80.7M↑88% | $17.8M↑36% | $19.6M↑73% | $67.7M↑186% | $23.7M↑162% | -$38.2M↑60% | -$94.9M↓2% | -$93.1M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Business Services
PHR vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUTOMATIC DATA PROCESSING INCADP | $122.3B | $309.93 | $21.9B | $4.4B | 73.2% | 0.82 | 24.2% | 1.05 | 4/9 | 5/9 | 3/7 | 0/3 | F-Score 6 | 5/11 |
| ELECTRONIC ARTS INC.EA | $52.9B | $209.70 | $7.5B | $887.0M | 13.1% | 0.22 | 15.4% | 1.05 | 1/9 | 4/9 | 4/7 | 0/3 | F-Score 6 | 6/11 |
| Rubrik, Inc.RBRK | $22.6B | $109.88 | $1.3B | $348.8M | 67.1% | — | -26.2% | 1.69 | 1/9 | 0/9 | 2/7 | 0/3 | F-Score 6 | 2/11 |
| AECOMACM | $9.1B | $70.50 | $16.1B | $561.8M | 22.5% | 1.09 | 6.4% | 1.14 | 1/9 | 3/9 | 3/7 | 1/3 | F-Score 8 | 2/11 |
| COMMVAULT SYSTEMS INCCVLT | $6.2B | $152.07 | $1.2B | $70.7M | 942.8% | — | 6.3% | 1.95 | 1/9 | 2/9 | 4/7 | 0/3 | F-Score 6 | 6/11 |
| WPP plcWPP | $6.0B | $27.79 | $18.2B | $289.5M | -8.5% | 1.94 | 2.8% | 0.89 | 1/9 | 2/9 | 1/7 | 0/3 | F-Score 3 | 2/11 |
| VARONIS SYSTEMS INCVRNS | $5.6B | $48.94 | $623.5M | $129.3M | -21.6% | 0.76 | -23.5% | 1.97 | 1/9 | 0/9 | 1/7 | 0/3 | F-Score 5 | 1/11 |
| ROBERT HALF INC.RHI | $4.3B | $42.00 | $5.4B | $133.0M | 10.4% | — | 1.4% | 1.53 | 2/9 | 5/9 | 1/7 | 0/3 | F-Score 5 | 2/11 |